{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:35:28Z","timestamp":1774701328163,"version":"3.50.1"},"reference-count":36,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5761\/atcs.oa.14-00345","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T22:06:11Z","timestamp":1439935571000},"page":"6-11","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma"],"prefix":"10.5761","volume":"22","author":[{"given":"Atsushi","family":"Osoegawa","sequence":"first","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"},{"name":"Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Kometani","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Fukuyama","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sugio","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"},{"name":"Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukito","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.","DOI":"10.1200\/JCO.2000.18.16.2938"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Golfinopoulos V, Salanti G, Pavlidis N, et al. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol 2007; 8: 898-911.","DOI":"10.1016\/S1470-2045(07)70281-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000; 343: 905-14.","DOI":"10.1056\/NEJM200009283431302"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Peeters M, Price TJ, Cervantes A, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol 2010; 28: 4706-13.","DOI":"10.1200\/JCO.2009.27.6055"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hochster HS, Hart LL, Ramanathan RK, et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol 2008; 26: 3523-9.","DOI":"10.1200\/JCO.2007.15.4138"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Grothey A, Van Cutsem E, Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 2013; 381: 303-12.","DOI":"10.1016\/S0140-6736(12)61900-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Giantonio BJ, Levy DE, O'dwyer PJ, et al. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann Oncol 2006; 17: 1399-403.","DOI":"10.1093\/annonc\/mdl161"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.","DOI":"10.1056\/NEJMoa032691"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 2010; 28: 4697-705.","DOI":"10.1200\/JCO.2009.27.4860"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 2009; 27: 663-71.","DOI":"10.1200\/JCO.2008.20.8397"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Van Cutsem E, K\u00f6hne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360: 1408-17.","DOI":"10.1056\/NEJMoa0805019"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yoshino T, Mizunuma N, Yamazaki K, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 2012; 13: 993-1001.","DOI":"10.1016\/S1470-2045(12)70345-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 1984; 3: 303-24.","DOI":"10.1007\/BF00051457"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150: 195-203.","DOI":"10.1002\/path.1711500308"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 2006; 82: 254-60.","DOI":"10.1016\/j.athoracsur.2006.02.027"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Inoue M, Kotake Y, Nakagawa K, et al. Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2000; 70: 380-3.","DOI":"10.1016\/S0003-4975(00)01417-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Landreneau RJ, De Giacomo T, Mack MJ, et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg 2000; 18: 671-6; discussion 676-7.","DOI":"10.1016\/S1010-7940(00)00580-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992; 53: 780-5; discussion 785-6.","DOI":"10.1016\/0003-4975(92)91435-C"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) McCormack PM, Burt ME, Bains MS, et al. Lung resection for colorectal metastases. 10-year results. Arch Surg 1992; 127: 1403-6.","DOI":"10.1001\/archsurg.1992.01420120037006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996; 112: 867-74.","DOI":"10.1016\/S0022-5223(96)70085-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pfannschmidt J, Muley T, Hoffmann H, et al. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 2003; 126: 732-9.","DOI":"10.1016\/S0022-5223(03)00587-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment. J Thorac Cardiovasc Surg 2002; 124: 1007-13.","DOI":"10.1067\/mtc.2002.125165"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shiono S, Ishii G, Nagai K, et al. Histopathologic prognostic factors in resected colorectal lung metastases. Ann Thorac Surg 2005; 79: 278-82; discussion 283.","DOI":"10.1016\/j.athoracsur.2004.06.096"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yano T, Hara N, Ichinose Y, et al. Results of pulmonary resection of metastatic colorectal cancer and its application. J Thorac Cardiovasc Surg 1993; 106: 875-9.","DOI":"10.1016\/S0022-5223(19)34042-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Rusch VW. Pulmonary metastasectomy. Current indications. Chest 1995; 107(6 Suppl): 322S-331S.","DOI":"10.1378\/chest.107.6_Supplement.322S"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sobin L, Wittekind C. TNM: classification of malignant tumours: John Wiley & Sons; 2002.","DOI":"10.1002\/0471463752"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American statistical association 1958; 53: 457-81.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. Journal of the Royal Statistical Society. Series A (General) 1972; 135: 185-207.","DOI":"10.2307\/2344317"},{"key":"29","unstructured":"29) Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society. Series B (Methodological) 1972; 34: 187-220."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 2013; 48: 452-8.","DOI":"10.1038\/bmt.2012.244"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) McCormack P. Surgical resection of pulmonary metastases. Semin Surg Oncol 1990; 6: 297-302.","DOI":"10.1002\/ssu.2980060513"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984; 38: 323-30.","DOI":"10.1016\/S0003-4975(10)62280-1"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Takita H, Merrin C, Didolkar MS, et al. The surgical management of multiple lung metastases. Ann Thorac Surg 1977; 24: 359-64.","DOI":"10.1016\/S0003-4975(10)63415-7"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007; 84: 324-38.","DOI":"10.1016\/j.athoracsur.2007.02.093"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Iida T, Nomori H, Shiba M, et al. Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysis. Ann Surg 2013; 257: 1059-64.","DOI":"10.1097\/SLA.0b013e31826eda3b"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47: 624-30.","DOI":"10.1093\/clinchem\/47.4.624"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/22\/1\/22_oa.14-00345\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:13:27Z","timestamp":1599470007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/22\/1\/22_oa.14-00345\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.14-00345","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}